Structure Therapeutics In...

15.81
-1.50 (-8.67%)
At close: Apr 01, 2025, 3:59 PM
16.03
1.38%
After-hours: Apr 01, 2025, 07:33 PM EDT

Structure Therapeutics Balance Sheet Statement

Year FY24 FY23 FY22 FY21 FY20
Cash & Equivalents 169.51M 129.79M 90.84M 105.31K 16.35K
Short-Term Investments 714.01M 337.53M 64.75M 2K 21.09K
Long-Term Investments n/a n/a n/a n/a n/a
Other Long-Term Assets 5.11M 45K 3.46M 111.00 8.00
Receivables n/a n/a n/a n/a n/a
Inventory n/a n/a n/a n/a n/a
Other Current Assets 7.69M 6.29M 2.25M n/a n/a
Total Current Assets 891.21M 473.61M 93.09M 109.25K 38.42K
Property-Plant & Equipment 7.01M 8.36M 1.29M 1.79K 277.00
Goodwill & Intangibles n/a n/a n/a n/a n/a
Total Long-Term Assets 12.12M 8.41M 4.76M 1.91K 285.00
Total Assets 903.33M 482.02M 97.84M 111.16K 38.7K
Account Payables 8.02M 4.74M 6.01M 3.48M 1.53M
Deferred Revenue n/a n/a n/a n/a n/a
Short-Term Debt 1.7M n/a 260K n/a n/a
Other Current Liabilities 26.3M 13.88M 3.28M -8.42M -2.49M
Total Current Liabilities 36.02M 24.74M 13.01M 8.66K 3.04K
Long-Term Debt 2.16M n/a n/a n/a n/a
Other Long-Term Liabilities 302K 298K n/a -104.77K -74.87K
Total Long-Term Liabilities 2.47M 4.31M 199.97M 167.23K 58.13K
Total Liabilities 38.49M 29.05M 212.99M 175.89K 61.17K
Total Debt 3.86M 5.45M 260K 621.00 280.00
Common Stock 17K 14K 1K 1.00 1.00
Retained Earnings -329.1M -206.57M -116.95M -64.74K -22.95K
Comprehensive Income 914K 521K -110K -166.96M -1
Shareholders Equity 864.84M 452.97M -115.14M -64.73K -22.47K
Total Investments 714.01M 337.53M 64.75M 2K 21.09K